Trial Profile
Study of Daily Oral Tenofovir (Tenofovir Disoproxil Fumarate) to Prevent HIV-1 Infection Among Sex Workers in Cambodia
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase II/III
Latest Information Update: 16 Dec 2016
Price :
$35
*
At a glance
- Drugs Tenofovir disoproxil fumarate (Primary)
- Indications HIV-1 infections
- Focus Therapeutic Use
- 13 Dec 2016 Status changed from discontinued to withdrawn prior to enrolment.
- 03 Jun 2011 New trial record